
Opinion|Videos|January 20, 2025
Treatment Choices For PPD and Peripartum Depression
Panelists discuss the strategic decision-making process for choosing among selective serotonin reuptake inhibitors (SSRIs), rapid-onset treatments like zuranolone, and nonmedication therapies for postpartum depression (PPD), emphasizing the importance of treatment speed, severity of symptoms, and patient preferences.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Depression and Long COVID Outcomes in Women: New Data Analysis
2
Investigational Psilocybin for PTSD and Ongoing Trials
3
Presenting Our February 2026 Theme: Bipolar Disorder
4
Increasing Prevalence of Long-Term Antidepressant Use in Australia: A Retrospective Observational Study
5






